Research Article
MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection
Table 3
Results of the Cox regression to evaluate independent risk factors affecting overall survival of all patients in this study.
| Characteristics | Univariable analysis | Multivariable analysis | HR | 95% CI of HR | value | HR | 95% CI of HR | value |
| Sex | 1.512 | 0.613–3.725 | 0.369 | | | | Age (≥60) | 0.540 | 0.233–1.251 | 0.151 | | | | Stage (III/IV) | 0.410 | 0.151–1.113 | 0.080 | | | | IPI (>2) | 3.876 | 1.572–9.524 | 0.003 | 4.274 | 1.721–10.638 | 0.002 | Ki-67 (>80%) | 2.036 | 0.602–6.884 | 0.252 | | | | Molecular subtype | 0.605 | 0.222–1.645 | 0.325 | | | | Rituximab | 0.404 | 0.172–0.949 | 0.038 | 0.333 | 0.135–0.820 | 0.017 | MYC positive | 4.274 | 1.553–11.765 | 0.005 | 5.556 | 1.706–18.182 | 0.004 | BCL2 positive | 0.507 | 0.166–1.545 | 0.232 | | | | HBV status | 2.338 | 1.006–5.432 | 0.048 | 1.215 | 0.487–3.034 | 0.677 |
|
|
Note. HR, hazard ratio; CI, confidence index; IPI, international prognostic index.
|